BLOOD PRESSURE MONITORING TESTING MARKET ANALYSIS

Blood Pressure Monitoring Testing MarketSize and Trends

The global blood pressure monitoring testing drugs market is estimated to be valued at US$ 4,560.1 million in 2021 and is expected to exhibit a CAGR of 11.7% over the forecast period (2021-2028).

Market Trends

Major players in the market are focused on adopting partnership strategies to expand their product portfolio. For instance, in April 2020, OMRON Healthcare, Co., Ltd. partnered with AliveCor, Inc. to integrate AliveCor’s ECG technology with blood pressure devices from OMRON for non-invasive remote monitoring devices.

Major players in the market are also focused on increasing awareness regarding cardiovascular diseases. For instance, in September 2019, Withings sas partnered with the World Heart Federation to raise awareness of cardiovascular diseases.

Key Takeaways of the Graph:

• Among Product Type, the Sphygmomanometer/Aneroid BP Monitors held dominant position in the market and accounted for 50.0% share in the global blood pressure monitoring testing market in 2020. The segment is expected to reach US$ 4,417.1 million in 2028.
• Sphygmomanometer/Aneroid BP Monitors dominated the global market in 2020, owing to new product launches, innovative product developments with advanced technologies, and rising adoption of home blood pressure monitoring trend.
• Among end user, hospitals held dominant position in the market and accounted for 61.3% share in the global blood pressure monitoring testing market in 2020. The segment is expected to reach US$ 6,167.9 million in 2028.
• Dominance of hospitals segment can be ascribed to growing adoption of BP monitoring devices, and presence of a large patient pool with need for cost-effective, fast, and accurate diagnostic tools for better health outcomes in hospitals

Market Trends

Major players in the market are focused on adopting partnership strategies to expand their product portfolio. For instance, in April 2020, OMRON Healthcare, Co., Ltd. partnered with AliveCor, Inc. to integrate AliveCor’s ECG technology with blood pressure devices from OMRON for non-invasive remote monitoring devices.

Major players in the market are also focused on increasing awareness regarding cardiovascular diseases. For instance, in September 2019, Withings sas partnered with the World Heart Federation to raise awareness of cardiovascular diseases.

Key Takeaways of the Graph:

• Among Product Type, the Sphygmomanometer/Aneroid BP Monitors held dominant position in the market and accounted for 50.0% share in the global blood pressure monitoring testing market in 2020. The segment is expected to reach US$ 4,417.1 million in 2028.
• Sphygmomanometer/Aneroid BP Monitors dominated the global market in 2020, owing to new product launches, innovative product developments with advanced technologies, and rising adoption of home blood pressure monitoring trend.
• Among end user, hospitals held dominant position in the market and accounted for 61.3% share in the global blood pressure monitoring testing market in 2020. The segment is expected to reach US$ 6,167.9 million in 2028.
• Dominance of hospitals segment can be ascribed to growing adoption of BP monitoring devices, and presence of a large patient pool with need for cost-effective, fast, and accurate diagnostic tools for better health outcomes in hospitals